LondonG.M., GuerinA.P., MarchaisS.J., PannierB., SafarM.E., DayM.Cardiac and arterial interactions in end-stage renal disease.Kidney Int1996; 50: 600–8.
2.
BlacherJ., GuerinA.P., PannierB., MarchaisS.J., SafarM.E., LondonG.M.Impact of aortic stiffness on survival in end-stage renal disease.Circulation1999; 11: 2434–9.
3.
BarenbrockM., SpiekerC., LaskeV., HeidenreichS., HohageH., BachmannJ.Studies of the vessel wall properties in HD patients.Kidney Int1994; 45: 1397–400.
4.
KoningsC.J., DammersR., RensmaP.L., KoomanJ.P., HoeksA.P., KornetL.Arterial wall properties in patients with renal failure.Am J Kidney Dis2002; 39: 1206–12.
5.
MeeusF., KourilskyO., GuerinA.P., GaudryC., MarchaisS.J., LondonG.M.Pathophysiology of cardiovascular disease in hemodialysis patients.Kidney Int Suppl2000; 76: S140–7.
BlacherJ., GuerinA.P., PannierB., MarchaisS.J., LondonG.M.Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease.Hypertension2001; 38: 938–42.
8.
Tycho VuurmansJ.L., BoerW.H., BosW.J., BlankestijnP.J., KoomansH.A.Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients.J Am Soc Nephrol2002; 13: 177–83.
9.
LinY.P., YuW.C., HsuT.L., DingP.Y., YangW.C., ChenC.H.The extracellular fluid-to-intracellular fluid volume ratio is associated with large-artery structure and function in hemodialysis patients.Am J Kidney Dis2003; 42: 990–9.
10.
KoschM., BarenbrockM., KistersK., RahnK.H., HausbergM.Relationship between muscle sympathetic nerve activity and large artery mechanical vessel wall properties in renal transplant patients.J Hypertens2002; 20: 501–8.
11.
ZoccaliC., MallamaciF., MaasR., BenedettoF.A., TripepiG., MalatinoL.S.; CREED Investigators. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients.Kidney Int2002; 62: 339–45.
12.
IchiharaA., HayashiM., RyuzakiM., HandaM., FurukawaT., SarutaT.Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus.Nephrol Dial Transplant2002; 17: 1513–17.
13.
BeerenhoutC.M., KoningsC.J., DammersR., RensmaP.L., HoeksA.P., GladziwaU.Determinants of arterial distensibility in patients with renal failure.Nephron Physiol2003; 95: 43–8.
14.
StewartA.D., MillasseauS.C., KearneyM.T., RitterJ.M., ChowienczykP.J.Effects of inhibition of basal nitric oxide synthesis on carotid-femoral pulse wave velocity and augmentation index in humans.Hypertension2003; 42: 915–18.
15.
CovicA., GoldsmithD.J., Gusbeth-TatomirP., BuhaescuI., CovicM.Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients.Transplantation2003; 76: 1573–7.
16.
BarenbrockM., HausbergM., KoschM., KistersK., HoeksA.P., RahnK.H.A longitudinal study of vessel wall properties in normotensive and hypertensive renal transplant recipients.J Hum Hypertens1998; 12: 707–11.
LimaJ.J., VieiraM.L., VivianiL.F., MedeirosC.J., IanhezL.E., KopelL.Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients.Nephrol Dial Transplant2002; 17: 645–51.
19.
KoschM., HausbergM., SuwelackB.Studies on effects of calcineurin inhibitor withdrawal on arterial distensibility and endothelial function in renal transplant recipients.Transplantation2003; 76: 1516–19.
20.
TsaiP.S., YuchaC.B.Noninvasive measurement of central arterial pressure and distensibility by arterial applanation tonometry with a generalized transfer function: Implications for nursing.Heart Lung2001; 30: 437–44.
21.
O'RourkeM.F., StaessenJ.A., VlacapoulosC., DuprezD., PlanteG.E.Clinical applications of arterial stiffness; definitions and reference values.Am J Hypertens2002; 15: 426–44.
22.
LondonG.M., BlacherJ., PannierB., GuerinA.P., MarchaisS.J., SafarM.E.Arterial wave reflections and survival in end-stage renal failure.Hypertension2001; 38: 434–8.
23.
RenemanR.S., HoeksA.P.Noninvasive vascular ultrasound: An asset in vascular medicine.Cardiovasc Res2000; 45: 27–35.
24.
Van BortelL.M., BalkesteinE.J., van der Heijden-SpekJ.J., VanmolkotF.H., StaessenJ.A., KragtenJ.A.Noninvasive assessment of local arterial pulse pressure: Comparison of applanation tonometry and echo-tracking.J Hypertens2001; 19: 1037–44.
25.
MeindersJ.M., HoeksA.P.Simultaneous assessment of diameter and pressure waveforms in the carotid artery.Ultrasound Med Biol2004; 30: 147–54.
26.
KoningsC.J., KoomanJ.P., SchonckM., DammersR., CheriexE., Palmans MeulemansA.P.Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis.Perit Dial Int2002; 22: 477–87.
27.
BouthierJ.D., De LucaN., SafarM.E., SimonA.C.Cardiac hypertrophy and arterial distensibility in essential hypertension.Am Heart J1985; 109: 1345–52.
28.
BussyC., BoutouyrieP., LacolleyP., ChallandeP., LaurentS.Intrinsic stiffness of the carotid arterial wall material in essential hypertensives.Hypertension2000; 35: 1049–54.
29.
LaurentS., HayozD., TrazziS., BoutouyrieP., WaeberB., OmboniS.Isobaric compliance of the radial artery is increased in patients with essential hypertension.J Hypertens1993; 11: 89–98.
30.
MouradJ.J., GirerdX., BoutouyrieP., LaurentS., SafarM., LondonG.Increased stiffness of radial artery wall material in end-stage renal disease.Hypertension1997; 30: 1425–30.
31.
BalkesteinE.J., van Aggel-LeijssenD.P., van BaakM.A., Struijker-BoudierH.A., Van BortelL.M.The effect of weight loss with or without exercise training on large artery compliance in healthy obese men.J Hypertens1999; 17: 1831–5.
32.
SuzukiH., NakamotoH., OkadaH., SugaharaS., KannoY.A selective angiotensin receptor antagonist, valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness.Adv Perit Dial2003; 19: 59–66.
33.
GuerinA.P., BlacherJ., PannierB., MarchaisS.J., SafarM.E., LondonG.M.Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.Circulation2001; 103: 987–92.
34.
NakamuraT., KawagoeY., MatsudaT., TakahashiY., SekizukaK., EbiharaI.Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans.Kidney Blood Press Res2003; 26: 185–91.
35.
ChertowG.M., BurkeS.K., RaggiP; Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.Kidney Int2002; 62: 245–52.
